Predictions
ITM Power plc
Start price
Target price
Perf. (%)
€4.06
17.05.21
17.05.21
-
17.05.24
17.05.24
14.63%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
AFC Energy plc
Start price
Target price
Perf. (%)
€0.85
03.04.21
03.04.21
€1.80
03.10.21
03.10.21
-28.15%
03.10.21
03.10.21
Differentiated customer and product portfolio
Sustainability is important
Well known brand
Dialog Semiconductor plc
Start price
Target price
Perf. (%)
€53.34
26.01.21
26.01.21
€89.00
26.01.22
26.01.22
26.32%
27.09.21
27.09.21
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€4.48
14.09.21
14.09.21
-
14.09.22
14.09.22
-4.46%
19.09.21
19.09.21
Risky Investment
Vodafone Group
Start price
Target price
Perf. (%)
€1.56
23.04.21
23.04.21
-
23.04.22
23.04.22
-12.35%
17.09.21
17.09.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Increased challenges to pay loans and raise capital
Royal Mail plc
Start price
Target price
Perf. (%)
€4.19
03.10.18
03.10.18
€8.50
04.11.21
04.11.21
31.03%
09.09.21
09.09.21
Could be worthwhile Investment >10% per year
Proton Motor Power Systems plc
Start price
Target price
Perf. (%)
€0.47
01.03.21
01.03.21
-
01.03.22
01.03.22
-36.86%
12.07.21
12.07.21
Business model of the past or high risk
High risks for its business
Risky Investment
Pearson plc ADR
Start price
Target price
Perf. (%)
€8.65
27.03.21
27.03.21
€10.00
27.03.22
27.03.22
10.98%
01.07.21
01.07.21
Higher risks for its business
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€5.70
18.10.20
18.10.20
€2.00
04.11.21
04.11.21
-35.79%
26.06.21
26.06.21
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
GW Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€80.50
24.03.20
24.03.20
€180.00
04.11.21
04.11.21
127.33%
24.06.21
24.06.21
AstraZeneca plc
Start price
Target price
Perf. (%)
€95.39
20.08.20
20.08.20
€105.50
04.11.21
04.11.21
1.68%
14.06.21
14.06.21
Future proof or reliable business model
Small cyclical dependencies
Known brand
Astrazeneca ADR
Start price
Target price
Perf. (%)
€41.60
17.12.20
17.12.20
€48.00
17.12.21
17.12.21
9.86%
03.06.21
03.06.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Carnival plc
Start price
Target price
Perf. (%)
€14.95
06.01.21
06.01.21
-
06.01.22
06.01.22
27.76%
14.05.21
14.05.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
Significant cyclical dependencies
Nielsen Holdings
Start price
Target price
Perf. (%)
€16.30
23.12.20
23.12.20
-
23.12.21
23.12.21
31.29%
29.04.21
29.04.21
High dividend yield expected
Differentiated customer and product portfolio
Revenue decline/stagnation expected
Little innovation
AFC Energy plc
Start price
Target price
Perf. (%)
€0.85
18.01.21
18.01.21
€5.00
18.04.21
18.04.21
-1.65%
18.04.21
18.04.21
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BAE Systems plc
Start price
Target price
Perf. (%)
€16.45
03.04.21
03.04.21
€8.00
-
04.04.21
04.04.21
Could be worthwhile Investment >10% per year
AstraZeneca plc
Start price
Target price
Perf. (%)
€87.23
20.01.21
20.01.21
-
20.01.22
20.01.22
-1.82%
29.03.21
29.03.21
Small cyclical dependencies
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Carnival plc
Start price
Target price
Perf. (%)
€18.10
22.02.21
22.02.21
-
22.02.22
22.02.22
4.14%
24.03.21
24.03.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
AstraZeneca plc
Start price
Target price
Perf. (%)
€83.36
18.12.20
18.12.20
€90.00
-3.42%
11.03.21
11.03.21
Could be worthwhile Investment >10% per year
Higher risks for its business
Astrazeneca ADR
Start price
Target price
Perf. (%)
€41.40
22.02.21
22.02.21
-
22.02.22
22.02.22
0.00%
10.03.21
10.03.21
Could be worthwhile Investment >10% per year
Medium risks for its business
Small cyclical dependencies